[1]
“Stability indicating HPTLC method for simultaneous determination of Azelnidipine and Telmisartan combined tablet dosage form”, e J. Med. Pharm. Sci., vol. 2, no. 2, pp. 36–45, Jun. 2026, doi: 10.62046/53jkv323.